Ticker Scorecard - GALT Basics Company: Galectin Therapeutics Inc. IPO Date: October 1, 2002 Sector: Healthcare Industry: Biotech Activated in VL: True Average Daily Range Avg Daily Range: $0.14 | 3.85% Avg Daily Range (30 D): $0.03 | 2.44% Avg Daily Range (90 D): $0.07 | 3.55% Institutional Daily Volume Avg Daily Volume: .33M Avg Daily Volume (30 D): .26M Avg Daily Volume (90 D): .47M Trade Size Avg Trade Size (Sh.): 260 Avg Trade Size (Sh.) (30 D): 205 Avg Trade Size (Sh.) (90 D): 232 Institutional Trades Total Inst.Trades: 45 Avg Inst. Trade: $2M Avg Inst. Trade (30 D): $3.81M Avg Inst. Trade (90 D): $3.81M Avg Inst. Trade Volume: .38M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.2M Avg Closing Trade (30 D): $3.81M Avg Closing Trade (90 D): $3.81M Avg Closing Volume: 939.47K     News Jan 10, 2025 @ 1:00 PM Galectin Therapeutics to Present at the 2025 MASH-... Source: N/A Aug 13, 2024 @ 12:00 PM Galectin Therapeutics Reports Financial Results fo... Source: N/A Jun 4, 2024 @ 12:00 PM Galectin Therapeutics to Present at the European A... Source: Galectin Therapeutics Inc. May 15, 2024 @ 12:00 PM Galectin Therapeutics Reports Financial Results fo... Source: Galectin Therapeutics Inc. Apr 14, 2024 @ 11:51 AM Wall Street Breakfast: The Week Ahead Source: Wall Street Breakfast Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.18 $-.2 $-.19 Diluted EPS $-.18 $-.2 $-.19 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -11.22M $ -12.37M $ -11.49M Operating Income / Loss $ -9.07M $ -11.29M $ -9.65M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio     Splits Mar 23, 2012:   6:1